USPTO serial 98151440
EVIDIUM
Reviewed by CopyMark Law Group
Status 732Notice of Allowance
- Filing date
- Status date
- Registration date
- —
- Examiner
- VENGURLEKAR, SAGAR S
- Law office
- PETITIONS OFFICE
What this means
The USPTO has issued a Notice of Allowance. To complete registration you generally need to file a Statement of Use or an extension request before the deadline.
Need help with EVIDIUM?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Get help with this Notice of Allowance, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $449*
Plus Government fees of $450
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
SAN FRANCISCO, CA, US
SAN FRANCISCO, CA, US
Recovery Exploration Technologies, Inc.
San Francisco, CA, US
Other trademarks owned by Recovery Exploration Technologies, Inc.
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Tina Chen
Tina Chen BEYER LAW GROUP LLP2595 EAST BAYSHORE ROAD, SUITE 100PALO ALTO, CA 94303United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 009 | Digital and voice signal processors for use with mobile devices and tablets in the nature of a medical diagnostic apparatus that is capable of receiving voice input of symptoms for medical diagnostic purposes; digital and voice signal processors for mobile devices and for medical diagnosis; downloadable medical software for providing situational awareness of pertinent factors relating to diagnosis and treatment, in real-time validating or expanding differential diagnosis considerations, and providing suggestions to help optimize the current clinical workflow and downstream healthcare pathway for diagnosis and treatment; downloadable medical software for augmenting review of patient data including patient chart by highlighting diagnostic and treatment related factors and connecting to relevant evidence; downloadable medical software for enabling users to run scenarios based on their hypotheses against the patient data and mapping to medical evidence; downloadable medical software applications for helping determine medical diagnosis, predicting response to treatment, and next-best-treatment; downloadable real-time recommendation engine software based on artificial intelligence and algorithms for medical diagnosis and treatment; downloadable database management software in the field of medical diagnosis and treatment; downloadable computer software for assisting with medical diagnosis and treatment via a computer or communication network; downloadable software featuring real-time recommendation engines based on artificial intelligence and algorithms for medical diagnosis and treatment; downloadable software using automated algorithms, artificial intelligence, and computational evidence to provide situational awareness and next-best-action suggestions for the understanding, diagnosis, treatment and prevention of medical conditions; downloadable recommendation engine service based on artificial intelligence and algorithms featuring medical information in the field of augmented intelligence for medical decision support across all health fields; all of the foregoing specifically excluding goods used for diagnosis and treatment of veterinary conditions and animal disease | ACTIVE | — |
| 042 | Providing online non-downloadable medical software for providing situational awareness of pertinent factors relating to diagnosis and treatment, in real-time validating or expanding differential diagnosis considerations, and providing suggestions to help optimize the current clinical workflow and downstream healthcare pathway for diagnosis and treatment; providing online non-downloadable medical software for augmenting review of patient data including patient chart by highlighting diagnostic and treatment related factors and connecting to relevant evidence; providing online non-downloadable medical software for enabling users to run scenarios based on their hypotheses against the patient data and mapping to medical evidence; providing online non-downloadable medical software applications for helping determine medical diagnosis, predicting response to treatment, and next-best-treatment; providing online non-downloadable real-time recommendation engine software based on artificial intelligence and algorithms for medical diagnosis and treatment; providing online non-downloadable computer software for assisting with medical diagnosis and treatment via a computer or communication network; providing online non-downloadable software featuring real-time recommendation engines based on artificial intelligence and algorithms for medical diagnosis and treatment; providing online non-downloadable software using automated algorithms, artificial intelligence, and computational evidence to provide situational awareness and next-best-action suggestions for the understanding, diagnosis, treatment and prevention of medical conditions; Software as a service (SAAS) services featuring software using artificial intelligence and algorithms featuring medical information in the field of augmented intelligence for assisting medical decision support across all health fields; voice transcription tool, being online non-downloadable software, for mobile devices and tablets for receiving voice input of symptoms and transcribing the input for medical diagnostic purposes across all health fields; all of the foregoing specifically excluding services for diagnosis and treatment of veterinary conditions and animal disease | ACTIVE | — |
| 044 | Medical services, namely, medical diagnostic services via a computer or communication network using automated algorithms, artificial intelligence, and computational evidence; providing medical diagnostic services relating to the treatment of persons via Internet-connected computer software applications with automated algorithms, artificial intelligence, and computational evidence for helping determine medical diagnosis, predicting response to treatment, and next-best-treatment; medical analysis and diagnostic services relating to the treatment of persons using Internet-connected computer software applications with automated algorithms, artificial intelligence, and computational evidence for providing situational awareness of pertinent factors relating to diagnosis and treatment, in real-time validating or expanding differential diagnosis considerations, and providing suggestions to help optimize the current clinical workflow and downstream healthcare pathway for diagnosis and treatment; providing medical information in the nature of a recommendation engine on the Internet via a website based on artificial intelligence and algorithms featuring medical information in the field of augmented intelligence for medical decision support across all health fields; providing an online searchable database featuring health-related information in the field of medical diagnosis and treatment; all of the foregoing specifically excluding services for diagnosis and treatment of veterinary conditions and animal disease | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by EVIDIUM, INC.
- Other trademarks owned by EVIDIUM, INC.
- Other trademarks owned by Recovery Exploration Technologies, Inc.
- Other trademarks in Class 009
- Other trademarks in Class 042
- Other trademarks in Class 044
- Similar marks named EVIDIUM
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Aug 15, 2026 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Aug 14, 2026 | EX3G | SOU EXTENSION 3 GRANTED | — |
| Aug 14, 2026 | EXT3 | SOU EXTENSION 3 FILED | — |
| Aug 14, 2026 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Feb 10, 2026 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Feb 9, 2026 | EX2G | SOU EXTENSION 2 GRANTED | — |
| Feb 9, 2026 | EXT2 | SOU EXTENSION 2 FILED | — |
| Feb 9, 2026 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Aug 13, 2025 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Aug 12, 2025 | EX1G | SOU EXTENSION 1 GRANTED | — |
| Aug 12, 2025 | EXT1 | SOU EXTENSION 1 FILED | — |
| Aug 12, 2025 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Mar 19, 2025 | ASCK | ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY | — |
| Mar 3, 2025 | CHPB | POST PUBLICATION AMENDMENT - ENTERED | — |
| Mar 3, 2025 | APET | ASSIGNED TO PETITION STAFF | — |
| Feb 18, 2025 | NOAM | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| Jan 23, 2025 | EPPA | TEAS POST PUBLICATION AMENDMENT RECEIVED | — |
| Dec 24, 2024 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Dec 24, 2024 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Dec 18, 2024 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Dec 3, 2024 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Nov 1, 2024 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Nov 1, 2024 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Nov 1, 2024 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Oct 16, 2024 | ASGN | AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP | — |
| Jul 30, 2024 | XELG | APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED | — |
| Jul 30, 2024 | XELR | APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED | — |
| May 14, 2024 | LOPR | LETTER OF PROTEST EVIDENCE REVIEWED-NO FURTHER ACTION TAKEN | — |
| May 10, 2024 | LOPT | LETTER OF PROTEST EVIDENCE FORWARDED | — |
| May 2, 2024 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| May 2, 2024 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| May 2, 2024 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Apr 25, 2024 | DOCK | ASSIGNED TO EXAMINER | — |
| Sep 25, 2023 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Aug 29, 2023 | NWAP | NEW APPLICATION ENTERED | — |